Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer

CONTEXT: Five to 10% of patients with differentiated thyroid cancers (DTC) develop invasive and/or distant metastatic disease that is marginally improved with standard therapies. Prognosis is poor for patients with anaplastic thyroid cancer, with a median survival of 3–5 months. We suggest that a pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Endocrinol Metab
Hlavní autoři: Bastman, Jill J., Serracino, Hilary S., Zhu, Yuwen, Koenig, Michelle R., Mateescu, Valerica, Sams, Sharon B., Davies, Kurtis D., Raeburn, Christopher D., McIntyre, Robert C., Haugen, Bryan R., French, Jena D.
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929840/
https://ncbi.nlm.nih.gov/pubmed/27045886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-4227
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky